Cardiac troponin I and second-generation cardiac troponin T assays show similar changes and good correlation in patients with early posttraumatic rhabdomyolysis, suggesting both are specific for cardiac damage in this setting.
Answers are grounded in this paper and cite their sources.
May support either troponin assay for cardiac assessment in rhabdomyolysis; leaves open need for prospective validation before practice change.
Troponin T was proposed as an aid in the diagnosis of myocardial infarction in 1989 (1). However, the first generation of commercially available troponin T assays yielded false-positive results in patients with severe skeletal muscle injury because of an unspecific binding of skeletal muscle troponin T to the wall of the test tube. Indeed, the second detection antibody in the test showed marked cross-reactivity with skeletal muscle troponin T. Another protein of the troponin complex, cardiac troponin I (cTnI), recently became commercially available and was shown to be highly specific for cardiac muscle (2). cTnI can be used for the diagnosis of myocardial damage in patients with posttraumatic rhabdomyolysis (3). More recently, a cardiac-specific, second-generation assay for troponin T (cTnT) was developed by using a second completely cardiac-specific antibody (4). We report here the comparison of the results obtained for cTnI and cTnT in patients with early posttraumatic rhabdomyolysis [creatine kinase (CK) activity >4000 U/L; upper reference limit (URL), 110 U/L]. Total CK activity was assessed at 30 °C according to IFCC recommendations with a Hitachi 704 analyzer (Boehringer Mannheim). The intraassay reproducibility for CK (160 U/L) was 0.9% (n = 10). cTnI (routinely assayed in our laboratory) and cTnT were measured with commercially available immunoassays (Stratus cTnI from Dade and Elecsys cTnT from Boehringer Mannheim). The detection limits for cTnI and cTnT, as assessed by 10 determinations of a sample free of cTnI and cTnT, were 0.10 μg/L and 0.018 μg/L, respectively. Ten determinations of the same serum sample (intraassay reproducibility) showed CVs of 5.4% and 1.3% for cTnI and cTnT, respectively. The mean ± SD concentrations (μg/L) were: 2.79 ± 0.15 and 0.31 ± 0.04, respectively. The reference value was <1.6 μg/L for cTnI. The reported reference value for cTnT was <0.1 μg/L (4). To verify the URL for cTnT, cTnI and cTnT were measured in 50 patients admitted to our hospital for suspected myocardial infarction. The relationship between cTnI (x) and cTnT (y) was y = 0.147x − 0.144 (r = 0.900). Thus, a theoretical URL of 0.09 μg/L for cTnT was obtained, which is same as that recommended by the manufacturer. cTnI and cTnT were measured in 15 patients (median age, 59 years; range, 24–90 years; sex, 12 men and 3 women) with early posttraumatic rhabdomyolysis in the first 24 h after admission to the hospital. Four patients presented no detectable cTnI at admission, and the cTnT ranged from 0.01 to 0.038 μg/L, therefore being under the URL for cTnT. In these patients, CK was up to 480-fold above the URL. For the other patients (with increased CK from 31- to 1450-fold above the URL) with detectable cTnI at admission, a second analysis was performed 24 h later. Fig. 1 shows a close relationship (r = 0.837) between cTnI and cTnT for the 14 patients (24 samples) with rhabdomyolysis: 8 patients had both cTnI and cTnT below their respective URLs; 4 patients had both cTnI and cTnT above their respective URLs (maximal increase: 4.4- and 3.2-fold over the URL for cTnI and cTnT, respectively); and three samples from 2 patients had cTnI below the URL but cTnT above the URL (1.5- and 1.7-fold increase, respectively). In these two patients creatinine was >250 μmol/L. These results suggested that cTnT might be unexpectedly increased in renal failure. Although obtained with the first-generation troponin T, such a discordance between cTnI and cTnT was reported previously in renal disease (5). However, a lower URL for cTnI (about 0.6 μg/L) would give nearly complete concordance between cTnI and cTnT values. The cTnI URL used in our laboratory corresponds to the value for the diagnosis of acute myocardial infarction, but a cutoff of 0.4 μg/L has been used recently to predict the risk of mortality in patients with acute coronary syndrome (6). The last patient studied in this work had very high cTnI and cTnT values (239 and 17.7 μg/L, respectively), associated with a CK 277 times the URL (not shown on the figure). Thus, our results demonstrated that cTnI and second-generation troponin T showed similar changes in patients with early posttraumatic rhabdomyolysis. Relationship between cTnI (Ic) and cTnT (Tc) in 24 samples from 14 patients with posttraumatic rhabdomyolysis. The URL was 1.6 μg/L for cTnI and 0.1 μg/L for cTnC. Lab. de Biochim. Méd., Centre Hosp. Univ., 1 rue de Germont, 76031 Rouen, France We gratefully acknowledge P. Delie, Boehringer Mannheim France (Meylan, France) for kindly supplying the cTnT immunoassay used in this study.
No takes yet. Share an insight, caveat, or question.
Lavoinne et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: